Acute COVID

Acute COVID-19 is a respiratory illness caused by the coronavirus SARS-CoV-2, which emerged in late 2019 and caused a global pandemic (Hu B et al. (2021)). The virus spreads mainly through respiratory droplets during close contact and uses the host cell protease TMPRSS2 to help it enter cells. Common symptoms include fever, cough, fatigue and loss of smell. The disease ranges from asymptomatic infection to fulminant illness with sepsis and acute respiratory failure (Wiersinga WJ et al. (2020)).

Older adults and people with underlying conditions are at higher risk of severe disease (Hu B et al. (2021)). Severe COVID-19 can involve strong activation of coagulation, and hospitalized patients often need supplemental oxygen. Diagnosis is usually based on detecting viral RNA by PCR. Treatment centers on supportive care for hypoxic respiratory failure, with antiviral or anti-inflammatory drugs for selected patients (Wiersinga WJ et al. (2020)).

Differential abundance and machine learning analysis

This section presents the disease-specific results of the differential abundance and machine learning analyses. The analyses are reported for three comparisons: 1) disease vs. all other diseases, 2) disease vs. diseases from the same class, and 3) disease vs. healthy samples.

DIFFERENTIAL ABUNDANCE AND MACHINE LEARNING ANALYSIS
Technology
Olink Explore HT
SomaScan 11K
Comparison
Disease vs All other
Disease vs Class
Disease vs Healthy

COMPARE TECHNOLOGIES FOR THIS DISEASE
Fold change per technology · most differentially abundant proteins across technologies ·
Concordance: Olink HT vs SomaScan ·